Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01527253
Other study ID # AFC-Food Basket
Secondary ID
Status Completed
Phase N/A
First received January 31, 2012
Last updated May 22, 2014
Start date September 2011
Est. completion date December 2012

Study information

Verified date May 2014
Source Lund University
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

The study evaluates the effect of a diet combining two different functional concepts on markers associated to cardiometabolic risk. The functional concepts are selected on the basis of their reported ability to influence the inflammatory tonus. It is hypothesized that the medium-term consumption of a diet combining low GI-prebiotic foods may positively influence various biomarkers associated with the risk for developing metabolic syndrome and cardiometabolic disease. Also, the combination of functional mechanisms are expected to result in synergistic effects.


Description:

The intervention is carried out in healthy women following a randomized crossover design in which an "active" (functional") diet is compared with a control diet formulated in agreement with the Nordic Dietary Recommendations but lacking the functional ingredients of the active regime.

The active diet supplies important daily amounts of dried legumes and wholegrain cereal products.

Each dietary treatment is applied for 4 weeks separated by a 4-6 week washout period. Subjects are encouraged to maintain a stable body weight under the whole trial.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date December 2012
Est. primary completion date May 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 50 Years to 70 Years
Eligibility Inclusion Criteria:

- BMI between 25 and 32 kg/m2

Exclusion Criteria:

- Fasting blood glucose > 6.1 mmol/L

- Medication for high blood pressure and/or elevated blood cholesterol

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention


Intervention

Other:
Synergistic food basket
A low glycemic index diet enriched in dried legumes and wholegrain cereals is compared with a control regime lacking these functional ingredients for their ability to ameliorate different markers associated with the risk for developing cardiometabolic disease

Locations

Country Name City State
Sweden Antidiabetic Food Centre, Chemical Centre. Lund University Lund Skane

Sponsors (2)

Lead Sponsor Collaborator
Lund University Anti-Diabetic Food Centre

Country where clinical trial is conducted

Sweden, 

References & Publications (5)

Liljeberg HG, Akerberg AK, Björck IM. Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects. Am J Clin Nutr. 1999 Apr;69(4):647-55. — View Citation

Nilsson A, Ostman E, Preston T, Björck I. Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. Eur J Clin Nutr. 2008 Jun;62(6):712-20. Epub 2007 May 23. — View Citation

Nilsson AC, Ostman EM, Granfeldt Y, Björck IM. Effect of cereal test breakfasts differing in glycemic index and content of indigestible carbohydrates on daylong glucose tolerance in healthy subjects. Am J Clin Nutr. 2008 Mar;87(3):645-54. — View Citation

Nilsson AC, Ostman EM, Holst JJ, Björck IM. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr. 2008 Apr;138(4):732-9. — View Citation

Tovar J, Nilsson A, Johansson M, Björck I. Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women. Br J Nutr. 2014 Feb;111(4):706-14. doi: 10.1017 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in LDL cholesterol after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in LDL-cholesterol/HDL-cholesterol after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in fasting plasma triglycerides after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in fasting CRP after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in fasting plasma PYY after each dietary period Satiety signalling hormone PYY Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in fasting plasma insulin after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in fasting plasma glucose after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in fasting plasma PAI-1 after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in BMI after each dietary period Body Mass Index Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in blood pressure after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in HOMA-IR after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
Secondary Change from baseline in waist circumference after each dietary period Week 0 and after 4 weeks (Start and End of the intervention arm) No
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A

External Links